Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1986-6-2
|
pubmed:abstractText |
Sublethal doses (0.00, 0.25, 0.50 and 1.00 mg/kg b.w./day) of vomitoxin (deoxynivalenol; DON) were studied for their effects on humoral and cellular immunity and serum proteins of inbred, male Swiss Webster mice in a series of 4 separate experiments. Vomitoxin was added to basal diet (less than the detection limit, i.e., less than 0.05 micrograms of vomitoxin per g of feed) and administered to mice for 5 weeks beginning at 21 days of age. Mice in experiment 2 were fed the basal diet for 40 days in addition to the 5-week treatment with vomitoxin. The 1.00 mg/kg dose of vomitoxin resulted in a statistically significant reduction in the serum levels of alpha 1 and alpha 2-globulins, an increase in total serum albumin, and a reduction in feed consumption and body weight gain compared to the control group. The 0.50 mg/kg dose of vomitoxin resulted in significantly reduced serum levels of alpha 2- and beta-globulins while a significant reduction of feed consumption was evident only during Week 4. Similarly, body weight gain in this group of mice was significantly reduced during Week 2 but increased to normal levels during Week 3 and remained parallel to the control for Week 4 and 5. Both levels (0.50 and 1.00 mg/kg) of vomitoxin resulted in a reduced, dose-related, time-to-death interval following a challenge with L. monocytogenes and increased proliferative capacity of splenic lymphocyte cultures stimulated with the phytohemagglutinin P (PHA-P) mitogen compared to the control group of mice. The 0.25 mg/kg dose of vomitoxin did not have any significant effects on the parameters studied. A reasonable estimation of a 'no effect' level for immunologic effects in mice based on these and previous immunological studies would seem to be between 0.25 and 0.50 mg/kg b.w./day.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Sesquiterpenes,
http://linkedlifedata.com/resource/pubmed/chemical/Trichothecenes,
http://linkedlifedata.com/resource/pubmed/chemical/deoxynivalenol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0378-4274
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-50
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3518157-Administration, Oral,
pubmed-meshheading:3518157-Analysis of Variance,
pubmed-meshheading:3518157-Animals,
pubmed-meshheading:3518157-Antibody Formation,
pubmed-meshheading:3518157-Blood Proteins,
pubmed-meshheading:3518157-Body Weight,
pubmed-meshheading:3518157-Hemolytic Plaque Technique,
pubmed-meshheading:3518157-Immunity, Cellular,
pubmed-meshheading:3518157-Immunoglobulin M,
pubmed-meshheading:3518157-Lymphocyte Activation,
pubmed-meshheading:3518157-Male,
pubmed-meshheading:3518157-Mice,
pubmed-meshheading:3518157-Sesquiterpenes,
pubmed-meshheading:3518157-Spleen,
pubmed-meshheading:3518157-Trichothecenes
|
pubmed:year |
1986
|
pubmed:articleTitle |
Effects of deoxynivalenol (vomitoxin) on the humoral and cellular immunity of mice.
|
pubmed:publicationType |
Journal Article
|